In Court

OxyContin maker Purdue Pharma may settle legal claims with a new ‘public trust’ that would still be dedicated to profit

Two similarly ambitious efforts to build alternatives to the profit-driven pharmaceutical model during and immediately after World War II suggest …

Ranbaxy barred

A Shot of Medicines

Ranbaxy in a spot

No patent linkage

Bayer’s attempt to pre-empt Cipla’s cancer drug fails

The NATCO CL fallout

The compulsory licence granted to Natco may not be a trendsetter but it will shake up the pharmaceuticals market

Drugs and cosmetics amendment bill withdrawn from Rajya Sabha

Newer areas like stem cells, regenerative medicines, medical devices and clinical trial cannot be effectively regulated under the existing law, …

Why Americans pay more for prescription drugs than anywhere else globally

The root of the problem is a patent system that allows pharma companies to keep out competition and keep prices sky high

Microplastics all around: A silent epidemic

All types of sea creatures ingest microplastics; as they move up the food chain, the plastic ends up in the human gut

COVID-19 exposes India’s dependence on China for active pharma ingredients

India imports around 90 per cent of APIs used to make antibiotics, says an expert

Bedaquiline patent win is a half victory

India’s ability to eliminate its huge TB burden by 2025 will be a test of both its patent laws and healthcare policy

Fake medicines are a dangerous threat in Africa: 3 ways to spot them

The most common fakes tend to be the most popular medicines: Painkillers, antibiotics to treat infection, anti-malarials, anti-retrovirals, …

Monsanto's troublesome trait

Bayer is battling seed companies and farmers in several countries over royalty on Monsanto's GM seeds

The right pill

Africa will be setting up its first agency to check the spread of spurious drugs

Evergreening rampant in India

India's patent office has ignored the strict safeguards against evergreening and allowed a flood of secondary drug patents

Memories of a city

Book>> Ahmedabad, Shock city of Twentieth Century India, by Howard Spodek, Orient Blackswan, Rs 795

When Big Pharma has all the answers

IFPMA, the biopharma trade body, has made its claim clear: COVID-19 vaccine management should be left to these handful of companies; and all …

Germany to phase out glyphosate by 2023

The country took this step to protect insect populations that play a pivotal role in ecosystems and pollination of food crops

Second guilty verdict against Monsanto in the US

Federal jury finds that Monsanto’s Roundup herbicide caused a man’s cancer

Centre fails to weed out substandard drugs, reign in prices: Parl panel

It recommends that the government adopt cost of production-based pricing system

10 per cent drugs in government supply chain below standard

National drug survey published by the health ministry also found that 0.059 per cent of government-sourced samples were spurious

Big Pharma and intellectual property: Why is India afraid of compulsory licences?

While rich nations are discovering the virtues of compulsory drug licences, India has resolutely turned its back on this tool despite nudges from …

Vaccines without needles: New shelf-stable film could revolutionise how medicines are distributed worldwide

A research group claims to have developed a method to stabilise live viruses and other biological medicines in a rapidly dissolving film that …

In poll season, Punjab debates legalising poppy seed and opium farming

Proponents feel the two crops will help farmers, save Punjab’s groundwater and wean its youth from synthetic drugs